Hydroxyzine for Anxiety Treatment

Introduction to Hydroxyzine

• The European medical community suggests hydroxyzine acts as a sedative antihistamine with anxiolytic properties, approved for this use in both Europe and the United States 1, 2

Clinical Positioning and Guidelines

• The American Academy of Child and Adolescent Psychiatry recommends first-line treatments for generalized anxiety disorder (GAD) remain SSRIs and SNRIs based on robust evidence and guideline recommendations 3, 4
• Hydroxyzine is notably absent from major anxiety disorder treatment guidelines (NICE, S3, Canadian CPG, AACAP 2020) as a recommended agent 3, 4

Specific Clinical Scenarios

• The European Journal of Nuclear Medicine and Molecular Imaging suggests hydroxyzine is approved and practical for anxiolysis during medical procedures in pediatric populations 1, 2
• The Journal of the American Academy of Child and Adolescent Psychiatry indicates hydroxyzine can be used as chemical restraint in psychiatric settings for children and adolescents, though with important caveats 5, 6, 7

Adverse Effects and Precautions

• The British Journal of Dermatology states hydroxyzine is contraindicated in early pregnancy per UK manufacturer guidelines 8, 9, 10
• The British Journal of Dermatology also notes hydroxyzine should be avoided in severe liver disease due to inappropriate sedating effects 8, 9, 10

Key Clinical Pitfalls

• The Journal of the American Academy of Child and Adolescent Psychiatry advises against using hydroxyzine as PRN chemical restraint, as this practice is prohibited per JCAHO standards 5, 6
• The British Journal of Dermatology warns of the sedation profile of hydroxyzine, which may impair daytime function 8, 9